| Tocopherols in the prevention and treatment of atherosclerosis and related cardiovascular disease P Mathur, Z Ding, T Saldeen, JL Mehta Clinical cardiology 38 (9), 570-576, 2015 | 161 | 2015 |
| Gender-related differences in atherosclerosis P Mathur, B Ostadal, F Romeo, JL Mehta Cardiovascular drugs and therapy 29, 319-327, 2015 | 127 | 2015 |
| Artificial intelligence, machine learning, and cardiovascular disease P Mathur, S Srivastava, X Xu, JL Mehta Clinical Medicine Insights: Cardiology 14, 1179546820927404, 2020 | 117 | 2020 |
| The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma S Thanendrarajan, E Tian, P Qu, P Mathur, C Schinke, F van Rhee, ... Haematologica 102 (9), e364, 2017 | 79 | 2017 |
| Cross-talk between PCSK9 and damaged mtDNA in vascular smooth muscle cells: role in apoptosis Z Ding, S Liu, X Wang, P Mathur, Y Dai, S Theus, X Deng, Y Fan, ... Antioxidants & Redox Signaling 25 (18), 997-1008, 2016 | 73 | 2016 |
| Evolving role of telemedicine in health care delivery in India P Mathur, S Srivastava, A Lalchandani, JL Mehta Prim Health Care 7 (260), 2167-1079, 2017 | 57 | 2017 |
| Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease M Mohan, A Buros, P Mathur, N Gokden, M Singh, S Susanibar, ... American Journal of Hematology 92 (8), 739-745, 2017 | 51 | 2017 |
| Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report A Matin, S Sharma, P Mathur, SK Apewokin International journal of antimicrobial agents 49 (4), 488-492, 2017 | 36 | 2017 |
| The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype C Schinke, A Hoering, H Wang, V Carlton, S Thanandrarajan, ... Haematologica 102 (8), e313, 2017 | 27 | 2017 |
| Atrial fibrillation in hematologic malignancies, especially after autologous hematopoietic stem cell transplantation: review of risk factors, current management, and future … P Mathur, H Paydak, S Thanendrarajan, F van Rhee Clinical Lymphoma Myeloma and Leukemia 16 (2), 70-75, 2016 | 26 | 2016 |
| Biochemical basis and therapeutic implications of angiogenesis JL Mehta, NS Dhalla Springer, 2013 | 25 | 2013 |
| Cardiovascular complications of multiple myeloma in the elderly P Mathur, S Thanendrarajan, H Paydak, S Vallurupalli, K Jambhekar, ... Expert Review of Cardiovascular Therapy 15 (12), 933-943, 2017 | 18 | 2017 |
| Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs P Mathur, S Kadavath, JD Marsh, JL Mehta European Heart Journal 41 (48), 4577-4579, 2020 | 17 | 2020 |
| Severe right-sided heart failure and pulmonary hypertension with carfilzomib treatment in multiple myeloma P Mathur, S Thanendrarajan, A Lopez-Candales Heart Views 21 (4), 296-299, 2020 | 9 | 2020 |
| Nivolumab for treatment of advanced, refractory, high-risk multiple myeloma S Thanendrarajan, J Puryear, CD Schinke, F van Rhee, M Zangari, ... Blood 130, 1858, 2017 | 9 | 2017 |
| Feasibility of outpatient stem cell transplantation in multiple myeloma and risk factors predictive of hospital admission K Larsen, H Spencer, M Mohan, C Bailey, K Hill, M Kottarathara, R Parikh, ... Journal of Clinical Medicine 11 (6), 1640, 2022 | 6 | 2022 |
| Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant P Mathur, B Hollowoa, N Lala, S Thanendrarajan, A Matin, A Kothari, ... Hematology Reports 9 (3), 7094, 2017 | 6 | 2017 |
| Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going? S Thanendrarajan, FE Davies, GJ Morgan, C Schinke, P Mathur, ... Immunotherapy 8 (3), 367-384, 2016 | 6 | 2016 |
| Daytime or nighttime administration of antihypertensive medications? T Sharma, P Mathur, JL Mehta American Journal of Hypertension 33 (11), 987-989, 2020 | 5 | 2020 |
| Metastatic prostate cancer with bone marrow infiltration mimicking multiple myeloma P Mathur, D Alapat, M Kumar, S Thanendrarajan Clinical Case Reports 6 (2), 269, 2018 | 5 | 2018 |
